Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Multiple Myeloma 27 Lymphoma, Non-Hodgkin 21 Leukemia, Myeloid, Acute 15 Lymphoma 9 Hodgkin Disease 9 Neoplasms, Plasma Cell 5 Myelodysplastic Syndromes 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Leukemia 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Recurrence 2 Pancreatic Neoplasms 2 Gliosarcoma 2 Glioma 2 Glioblastoma 2 Warts 1 Pinealoma 1 Paraproteinemias 1 Ovarian Neoplasms 1 Neutropenia 1 Neuroectodermal Tumors, Primitive 1 Neuroblastoma 1 Medulloblastoma 1 Lymphoproliferative Disorders 1 Leukemia, Myeloid 1 Leukemia, Biphenotypic, Acute 1 Infections 1 Immunologic Deficiency Syndromes 1 Hematologic Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Children Cancer, Solid Tumor × plerixafor × Clear all

NCT01225419 2014-07-08

MEP1

University Hospital, Clermont-Ferrand

Phase 2 Completed

Other solid neoplasm

Children Cancer, Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡